Vivifi Life Sciences

Company snapshot

It all started with a dream. A dream to be a world-class pharmaceutical company of Indian origin, which can match international standards on all counts. We worked towards our goal with full enthusiasm and commitment. As a result today, Vivifi Life Science has already made its presence felt in the pharmaceutical world.Vivifi Life Science is one of India’s most respected pharmaceutical companies and

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Vivifi Life Sciences. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Vivifi Life Sciences.

1. May 26, 2026 Clinical update

   VV261 5mg group — Phase 1

View all clinical trial activity →

• What is Vivifi Life Sciences?

  Vigonvita Life Sciences is a pharma organization headquartered in CN. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (1).

• Is Vivifi Life Sciences publicly traded?

  Vivifi Life Sciences appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Vivifi Life Sciences develop or market?

  We link 1 drug profile(s) where Vivifi Life Sciences is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/vigonvita-life-sciences#company-drugs.

• What are the latest developments for Vivifi Life Sciences?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Vivifi Life Sciences focus on?

  No specific therapeutic focus areas are currently identified for Vivifi Life Sciences in our database.